Jonathan Yewdell Discusses Viral Immunology, Vaccine Development, Navigating a Scientific Career, and Offers Perspectives on Transforming Scientific Publishing and Research Education

Article Sidebar

HTML PDF
Published: Sep 27, 2024
DOI: https://doi.org/10.20411/pai.v9i2.753

Main Article Content

Neil S. Greenspan
Case Western Reserve University, Cleveland, Ohio

Abstract

In this interview, Jonathan Yewdell talks with Pathogens and Immunity senior editor Neil Greenspan about the evolution of viral immunology, highlighting his work and the contributions of other influential scientists. He emphasizes the importance of passion and collaboration in scientific research, illustrating the potential for groundbreaking discoveries through networking. He provides advice on navigating a scientific career, stressing the significance of strong mentorship. And he shares his perspective on transforming the scientific publishing industry and research education.

Downloads

Download data is not yet available.

Article Details

Issue
Vol. 9 No. 2 (2024): Volume 9, Number 2
Section
Interviews
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Pathogens and Immunity abides by Creative Commons BY 4.0:

http://creativecommons.org/licenses/by/4.0/

This license lets others distribute, remix, tweak, and build upon your work for any lawful purpose, even commercially, as long as they credit you for the original creation. This is the most accommodating of licenses offered. Recommended for maximum dissemination and use of licensed materials. The authors maintain copyright of their materal.

*Due to a template error on our pdfs, articles published from May 20, 2016 to June 24, 2022 incorrectly state the copyright is held by Pathogens and Immunity. Copyright of all articles is held by the authors of each article as noted in the above copyright policy.   

Author Biography

Neil S. Greenspan, Case Western Reserve University, Cleveland, Ohio

Dr. Neil Greenspan received his A.B., magna cum laude, in Biochemical Sciences from Harvard College in 1975. He then earned M.D. and Ph.D. (Immunology) degrees at the University of Pennsylvania. From 1981 until 1986, Dr. Greenspan was a Resident in Laboratory Medicine (Clinical Pathology) at Barnes Hospital, and from 1982-1985 he was a Postdoctoral Fellow in Molecular Immunology at Washington University, both in St. Louis. In 1986, Dr. Greenspan became a faculty member at the Case School of Medicine. He is currently Professor of Pathology at Case and the Director of the Histocompatibility and Immunogenetics Laboratory at University Hospitals Cleveland Medical Center.

Crossref
Scopus
Google Scholar
Europe PMC

References

1. Contributors W. Arthur D. Levinson [updated August 14, 2024]. Available from: https://en.wikipedia.org/wiki/Arthur_D._Levinson.

2. Sigal NH, Klinman NR. The B-cell clonotype repertoire. Adv Immunol. 1978;26:255-337.

doi: 10.1016/s0065-2776(08)60232-1. PubMed PMID: 99996.

3. Klinman NR. Purification and analysis of “monofocal” antibody. J Immunol. 1971;106(5):1345-52. PubMed PMID: 5103351.

4. Hornick CL, Karuch F. Antibody affinity. 3. The role of multivalance. Immunochemistry. 1972;9(3):325-40. doi: 10.1016/0019-2791(72)90096-1. PubMed PMID: 4556115.

5. HN E. General Immunology: Lippincott Williams And Wilkins; 1989.

6. Davis BD DR, Eisen HN, Ginsberg HS. Microbiology: Lippincott Williams & Wilkins; 1990.

7. Grebe KM, Hickman HD, Irvine KR, Takeda K, Bennink JR, Yewdell JW. Sympathetic nervous system control of anti-influenza CD8+ T cell responses. Proc Natl Acad Sci U S A. 2009;106(13):5300-5. doi: 10.1073/pnas.0808851106. PubMed PMID: 19286971; PMCID: PMC2664017.

8. Grebe KM, Takeda K, Hickman HD, Bailey AL, Embry AC, Bennink JR, Yewdell JW. Cutting edge: Sympathetic nervous system increases proinflammatory cytokines and exacerbates influenza A virus pathogenesis. J Immunol. 2010;184(2):540-4. doi: 10.4049/jimmunol.0903395. PubMed PMID: 20018617; PMCID: PMC2941093.

9. Suttle CA. Environmental microbiology: Viral diversity on the global stage. Nat Microbiol. 2016;1(11):16205. doi: 10.1038/nmicrobiol.2016.205. PubMed PMID: 27782140.

10. Suttle CA. Viruses in the sea. Nature. 2005;437(7057):356-61. doi: 10.1038/nature04160. PubMed PMID: 16163346.

11. Chen W, Anton LC, Bennink JR, Yewdell JW. Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses. Immunity. 2000;12(1):83-93. doi: 10.1016/s1074-7613(00)80161-2. PubMed PMID: 10661408.

12. Angeletti D, Gibbs JS, Angel M, Kosik I, Hickman HD, Frank GM, Das SR, Wheatley AK, Prabhakaran M, Leggat DJ, McDermott AB, Yewdell JW. Defining B cell immunodominance to viruses. Nat Immunol. 2017;18(4):456-63. doi: 10.1038/ni.3680. PubMed PMID: 28192417; PMCID: PMC5360521.

13. contributors W. There are unknown unknowns. Wikipedia, The Free Encyclopedia [cited 2024 August 17]. Available from: https://en.wikipedia.org/wiki/There_are_unknown_unknowns.

14. Dreyer G, Walker EW. Report Cxi. Observations on the Production of Immune Substances. Br Med J. 1909;1(2507):151. doi: 10.1136/bmj.1.2507.151-a. PubMed PMID: 20764250; PMCID: PMC2318166.

15. Linderman SL, Hensley SE. Antibodies with ‘Original Antigenic Sin’ Properties Are Valuable Components of Secondary Immune Responses to Influenza Viruses. PLoS Pathog. 2016;12(8):e1005806. doi: 10.1371/journal.ppat.1005806. PubMed PMID: 27537358; PMCID: PMC4990287.

16. Francis T. On the Doctrine of Original Antigenic Sin. Proceedings of the American Philosophical Society. 1960;104(6):572-8.

17. Gerhard W, Yewdell J, Frankel ME, Webster R. Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies. Nature. 1981;290(5808):713-7. doi: 10.1038/290713a0. PubMed PMID: 6163993.

18. Wilson IA, Skehel JJ, Wiley DC. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature. 1981;289(5796):366-73. doi: 10.1038/289366a0. PubMed PMID: 7464906.

19. Caton AJ, Brownlee GG, Yewdell JW, Gerhard W. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell. 1982;31(2 Pt 1):417-27. doi: 10.1016/0092-8674(82)90135-0. PubMed PMID: 6186384.

20. Yewdell JW, Gerhard W, Bachi T. Monoclonal anti-hemagglutinin antibodies detect irreversible antigenic alterations that coincide with the acid activation of influenza virus A/PR/834-mediated hemolysis. J Virol. 1983;48(1):239-48. doi: 10.1128/JVI.48.1.239-248.1983. PubMed PMID: 6193286; PMCID: PMC255340.

21. Yewdell JW, Taylor A, Yellen A, Caton A, Gerhard W, Bachi T. Mutations in or near the fusion peptide of the influenza virus hemagglutinin affect an antigenic site in the globular region. J Virol. 1993;67(2):933-42. doi: 10.1128/JVI.67.2.933-942.1993. PubMed PMID: 7678310; PMCID: PMC237447.

22. Russ G, Bennink JR, Bachi T, Yewdell JW. Influenza virus hemagglutinin trimers and monomers maintain distinct biochemical modifications and intracellular distribution in brefeldin A-treated cells. Cell Regul. 1991;2(7):549-63. doi: 10.1091/mbc.2.7.549. PubMed PMID: 1664239; PMCID: PMC361844.

23. Dersh D, Phelan JD, Gumina ME, Wang B, Arbuckle JH, Holly J, Kishton RJ, Markowitz TE, Seedhom MO, Fridlyand N, Wright GW, Huang DW, Ceribelli M, Thomas CJ, Lack JB, Restifo NP, Kristie TM, Staudt LM, Yewdell JW. Genome-wide Screens Identify Lineage- and Tumor-Specific Genes Modulating MHC-I- and MHC-II-Restricted Immunosurveillance of Human Lymphomas. Immunity. 2021;54(1):116-31 e10. doi: 10.1016/j.immuni.2020.11.002. PubMed PMID: 33271120; PMCID: PMC7874576.

24. Jongsma MLM, de Waard AA, Raaben M, Zhang T, Cabukusta B, Platzer R, Blomen VA, Xagara A, Verkerk T, Bliss S, Kong X, Gerke C, Janssen L, Stickel E, Holst S, Plomp R, Mulder A, Ferrone S, Claas FHJ, Heemskerk MHM, Griffioen M, Halenius A, Overkleeft H, Huppa JB, Wuhrer M, Brummelkamp TR, Neefjes J, Spaapen RM. The SPPL3-Defined Glycosphingolipid Repertoire Orchestrates HLA Class I-Mediated Immune Responses. Immunity. 2021;54(1):132-50 e9. doi: 10.1016/j.immuni.2020.11.003. PubMed PMID: 33271119; PMCID: PMC8722104.

25. Esquivel F, Yewdell J, Bennink J. RMA/S cells present endogenously synthesized cytosolic proteins to class I-restricted cytotoxic T lymphocytes. J Exp Med. 1992;175(1):163-8. doi: 10.1084/jem.175.1.163. PubMed PMID: 1309852; PMCID: PMC2119061.

26. Purcell AW, Croft NP, Tscharke DC. Immunology by numbers: quantitation of antigen presentation completes the quantitative milieu of systems immunology! Curr Opin Immunol. 2016;40:88-95. doi: 10.1016/j.coi.2016.03.007. PubMed PMID: 27060633.

27. Yewdell JW, Anton LC, Bennink JR. Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules? J Immunol. 1996;157(5):1823-6. PubMed PMID: 8757297.

28. Zanker DJ, Oveissi S, Tscharke DC, Duan M, Wan S, Zhang X, Xiao K, Mifsud NA, Gibbs J, Izzard L, Dlugolenski D, Faou P, Laurie KL, Vigneron N, Barr IG, Stambas J, Van den Eynde BJ, Bennink JR, Yewdell JW, Chen W. Influenza A Virus Infection Induces Viral and Cellular Defective Ribosomal Products Encoded by Alternative Reading Frames. J Immunol. 2019;202(12):3370-80. doi: 10.4049/jimmunol.1900070. PubMed PMID: 31092636; PMCID: PMC6681668.

29. Hogan MJ, Maheshwari N, Begg BE, Nicastri A, Hedgepeth EJ, Muramatsu H, Pardi N, Miller MA, Reilly SP, Brossay L, Lynch KW, Ternette N, Eisenlohr LC. Cryptic MHC-E epitope from influenza elicits a potent cytolytic T cell response. Nat Immunol. 2023;24(11):1933-46. doi: 10.1038/s41590-023-01644-5. PubMed PMID: 37828378.

30. Netzer N, Goodenbour JM, David A, Dittmar KA, Jones RB, Schneider JR, Boone D, Eves EM, Rosner MR, Gibbs JS, Embry A, Dolan B, Das S, Hickman HD, Berglund P, Bennink JR, Yewdell JW, Pan T. Innate immune and chemically triggered oxidative stress modifies translational fidelity. Nature. 2009;462(7272):522-6. doi: 10.1038/nature08576. PubMed PMID: 19940929; PMCID: PMC2785853.

31. Norbury CC, Malide D, Gibbs JS, Bennink JR, Yewdell JW. Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo. Nat Immunol. 2002;3(3):265-71. doi: 10.1038/ni762. PubMed PMID: 11828323.

32. Hickman HD, Takeda K, Skon CN, Murray FR, Hensley SE, Loomis J, Barber GN, Bennink JR, Yewdell JW. Direct priming of antiviral CD8+ T cells in the peripheral interfollicular region of lymph nodes. Nat Immunol. 2008;9(2):155-65. doi: 10.1038/ni1557. PubMed PMID: 18193049.

33. Hickman HD, Li L, Reynoso GV, Rubin EJ, Skon CN, Mays JW, Gibbs J, Schwartz O, Bennink JR, Yewdell JW. Chemokines control naive CD8+ T cell selection of optimal lymph node antigen presenting cells. J Exp Med. 2011;208(12):2511-24. doi: 10.1084/jem.20102545. PubMed PMID: 22042976; PMCID: PMC3256957.

34. Reynoso GV, Weisberg AS, Shannon JP, McManus DT, Shores L, Americo JL, Stan RV, Yewdell JW, Hickman HD. Lymph node conduits transport virions for rapid T cell activation. Nat Immunol. 2019;20(5):602-12. doi: 10.1038/s41590-019-0342-0. PubMed PMID: 30886418; PMCID: PMC6474694.

35. Schwartz DH, Hurwitz JL, Greenspan NS, Doherty PC. Priming of virus-immune memory T cells in newborn mice. Infect Immun. 1984;43(1):202-5. doi: 10.1128/iai.43.1.202-205.1984. PubMed PMID: 6606624; PMCID: PMC263410.

36. Hosaka Y, Sasao F, Ohara R. Cell-mediated lysis of heat-inactivated influenza virus-coated murine targets. Vaccine. 1985;3(3 Suppl):245-51. doi: 10.1016/0264-410x(85)90116-1. PubMed PMID: 3877382.

37. Yewdell JW, Bennink JR, Hosaka Y. Cells process exogenous proteins for recognition by cytotoxic T lymphocytes. Science. 1988;239(4840):637-40. doi: 10.1126/science.3257585. PubMed PMID: 3257585.

38. Neijssen J, Herberts C, Drijfhout JW, Reits E, Janssen L, Neefjes J. Cross-presentation by intercellular peptide transfer through gap junctions. Nature. 2005;434(7029):83-8. doi: 10.1038/nature03290. PubMed PMID: 15744304.

39. Chen W, Masterman KA, Basta S, Haeryfar SM, Dimopoulos N, Knowles B, Bennink JR, Yewdell JW. Cross-priming of CD8+ T cells by viral and tumor antigens is a robust phenomenon. Eur J Immunol. 2004;34(1):194-9. doi: 10.1002/eji.200324257. PubMed PMID: 14971045.

40. Zinkernagel RM. On cross-priming of MHC class I-specific CTL: rule or exception? Eur J Immunol. 2002;32(9):2385-92. doi: 10.1002/1521-4141(200209)32:9<2385::

AID-IMMU2385>3.0.CO;2-V. PubMed PMID: 12207322.

41. Yewdell JW. Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses. Immunity. 2006;25(4):533-43. doi: 10.1016/j.immuni.2006.09.005. PubMed PMID: 17046682.

42. Lives saved by COVID‐19 vaccines. J Paediatr Child Health. 2022.

43. Yewdell JW. Individuals cannot rely on COVID-19 herd immunity: Durable immunity to viral disease is limited to viruses with obligate viremic spread. PLoS Pathog. 2021;17(4):e1009509. doi: 10.1371/journal.ppat.1009509. PubMed PMID: 33901246; PMCID: PMC8075217.

44. Picker LJ, Lifson JD, Gale M, Jr., Hansen SG, Fruh K. Programming cytomegalovirus as an HIV vaccine. Trends Immunol. 2023;44(4):287-304. doi: 10.1016/j.it.2023.02.001. PubMed PMID: 36894436; PMCID: PMC10089689.

45. Caini S, Meijer A, Nunes MC, Henaff L, Zounon M, Boudewijns B, Del Riccio M, Paget J. Probable extinction of influenza B/Yamagata and its public health implications: a systematic literature review and assessment of global surveillance databases. Lancet Microbe. 2024;5(8):100851. doi: 10.1016/S2666-5247(24)00066-1. PubMed PMID: 38729197.

46. Yewdell J. An Enron of Our Own. Science. 2022 August 30.

Most read articles by the same author(s)